Although guidelines suggest that men are 75 years or older may not benefit from screening, surveys continue to show high screening in this population. Since most screening and treatment for prostate cancer trials systematically older men are excluded, there are no well-characterized data on survival and quality-of – life issues. Of these,ublished in a population-based cohort study in May edition of the American Journal of Medicine, researchers followed 465 men aged 75-84, who had been diagnosed with clinically localized prostate cancer in 1994 or 1995 medical care . Of these, 175 patients received aggressive treatment and 290 received hormone therapy or no treatment. The authors evaluated health-related quality of life outcomes and survival 2 years after the original diagnosis. Survival was 7 years after 7 years after diagnosis. Writing in the article, Richard M. Hoffman, of the Medicine Service, New Mexico VA Healthcare System and the University of New Mexico Cancer Research and Treatment Center, summarized: Aggressive treatment minimally reduced the risk of prostate cancer to die; disease-specific survival was relatively high in both groups because most deaths were other reasons but received by 24 months after diagnosis, men who had more aggressive treatment of urinary and bowel dysfunction and were more bothered by suffering. Sexual dysfunction. General health and physical function were higher aggressively treated men, but this was probably due to residual selection bias. Our results reinforce concerns that men 75 years and older can not benefit from prostate cancer screening because they may suffer negative consequences of aggressive treatment of localized disease. .

###The article Health Outcomes in Older Men with localized prostate cancer: Results from the Prostate Cancer Outcomes Study by Richard M. Hoffman, Michael J. Janet L Stanford, Hamilton, William C. And Mary. McNaughton Collins, appears in the American Journal of Medicine, Volume 119, Number 5 Elsevier Elsevier.

same ingredients

12:45 Lunch and disclosure on Ian Donald bust13:50 ultrasound screening during pregnancy – of the cart before the horse Prof. Martin Whittle, Clinical Co-Director, London.

Other articles from category "beauty":

Random articles